Summary
This prediction ended on 26.02.22 with a price of €50.75. With a performance of -2.82%, the BUY prediction by Maleri finished with a loss. Maleri has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bayer AG | 4.428% | 4.428% | -54.383% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to Maleri what are the pros and cons of Bayer AG for the foreseeable future?
Pros
Revenue growth > 30% per year expected
Undervalued
High Investments for future growth
Top Rating
EBIT growth > 30% per year expected
Leading role in innovation
Sustainability is very important
Growths much faster than the competition
Capable Management
Very small cyclical dependencies
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Medium risks for its business
Strong uniques
Very good company culture
Market Leader or Top 3
Well known brand
Cons
Comments by Maleri for this prediction
In the thread Bayer AG diskutieren
Buy Bayer AG